Huons wins IND approval for Phase 2 dry eye drug trial – The Korea Herald

dry eye treatment candidate. HUC1-394 is a peptide-based ophthalmic solution licensed from Novacell Technology. The drug selectively binds to …

Source: google.com

Scroll to Top